Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation

Nicotine and Tobacco Research

Volumn 7, Issue 5, 2005, Pages 725-728

  Berlin, Ivan ^a   Covey, Lirio S ^b   Jiang, Huiping ^b   Hamer, Dean ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEFLOXATONE; CARBON MONOXIDE; DOPAMINE 2 RECEPTOR; GENOMIC DNA; NICOTINE; PLACEBO; TAQ POLYMERASE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DNA EXTRACTION; DOUBLE BLIND PROCEDURE; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCORING SYSTEM; SELF REPORT; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

ADULT; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; SMOKING CESSATION; TAQ POLYMERASE;

EID: 28244490238     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200500259176     Document Type: Article

References (11)

1. Berlin, I., de Brettes, B., Aymard, G., Diquet, B., Arnulf, I., & Puech, A. J. (2000). Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor. International Journal of Neuropsychopharmacology, 3, 35-43.
2. Cinciripini, P. M., Wetter, D. W., Tomlinson, G. E., Tsoh, J. Y., De Moor, C. A., Cinciripini, L. G., & Minna, J. D. (2004). The effects of the DRD2 polymorphism on smoking cessation and negative affect: Evidence for a pharmacogenetic effect on mood. Nicotine & Tobacco Research, 6, 229-239.
3. Comings, D. E., Ferry, L., Bradshaw-Robinson, S., Burchette, R., Chiu, C., & Muhleman, D. (1996). The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics, 6, 73-79.
4. Comings, D. E., Muhleman, D., Ahn, C., Gysin, R., & Flanagan, S. D. (1994). The dopamine D2 receptor gene: A genetic risk factor in substance abuse. Drug and Alcohol Dependence, 34, 175-180.
5. Grandy, D. K., Zhang, Y., & Civelli, O. (1993). PCR detection of the TaqA RFLP at the DRD2 locus. Human Molecular Genetics, 2, 2197.
6. Jonsson, E. G., Nothen, M. M., Grunhage, F., Farde, L., Nakashima, Y., Propping, P., & Sedvall, G. C. (1999). Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry, 4, 290-296.
7. Jonsson, E. G., Sedvall, G., Brene, S., Gustavsson, J. P., Geijer, T., Terenius, L., Crocq, M. A., Lannfelt, L., Tylec, A., Sokoloff, P., Schwartz, J. C., & Wiesel, F. A. (1996). Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biological Psychiatry, 40, 1032-1043.
8. Lerman, C., Shields, P. G., Wileyto, E. P., Audrain, J., Hawk, L. H., Pinto, A., Kucharski, S., Krishnan, S., Niaura, R., & Epstein, L. H. (2003). Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychology, 22, 541-548.
9. Noble, E. P., St Jeor, S. J., Ritchie, T., Syndulko, K., St Jeor, S. C., Fitch, R. J., Brunner, R. L., & Sparkes, R. S. (1994). D2 dopamine receptor gene and cigarette smoking: A reward gene? Medical Hypotheses, 42, 257-260.
10. Wolfinger, R. (1993). Covariance structure selection in general mixed models. Communications in Statistics: Simulations, 22, 1079-1106.
11. Yudkin, P., Munafò, M., Hey, K., Roberts, S., Welch, S., Johnstone, E., Murphy, M., Griffiths, S., & Walton, R. (2004). Effectiveness of nicotine patches in relation to genotype in women versus men: Randomised controlled trial. British Medical Journal, 328, 989-990.